Diffusion Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
Commenced Patient Enrollment in Phase 2 On-Ambulance TSC Clinical Trial for the Treatment of StrokeReported Favorable Safety Data in Glioblastoma […]